Charles River Laboratories International (CRL)
(Real Time Quote from BATS)
$221.89 USD
+3.65 (1.67%)
Updated Jul 22, 2024 11:10 AM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/7/24 |
---|---|
Current Quarter | 2.39 |
EPS Last Quarter | 2.27 |
Last EPS Surprise | 10.73% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 10.99 |
Next Year | 12.35 |
EPS (TTM) | 10.14 |
P/E (F1) | 19.86 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.03B | 1.07B | 4.21B | 4.54B |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 1.05B | 1.08B | 4.25B | 4.57B |
Low Estimate | 1.01B | 1.06B | 4.20B | 4.46B |
Year ago Sales | 1.06B | 1.03B | 4.13B | 4.21B |
Year over Year Growth Est. | -3.28% | 4.40% | 2.04% | 7.70% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.39 | 3.01 | 10.99 | 12.35 |
# of Estimates | 8 | 6 | 9 | 9 |
Most Recent Consensus | 2.38 | 3.00 | 10.93 | 12.28 |
High Estimate | 2.43 | 3.11 | 11.27 | 12.71 |
Low Estimate | 2.36 | 2.84 | 10.59 | 11.88 |
Year ago EPS | 2.69 | 2.72 | 10.67 | 10.99 |
Year over Year Growth Est. | -11.15% | 10.66% | 3.00% | 12.37% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 1 | 1 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.39 | 3.01 | 10.99 | 12.35 |
7 Days Ago | 2.39 | 3.01 | 11.00 | 12.36 |
30 Days Ago | 2.39 | 3.01 | 11.00 | 12.36 |
60 Days Ago | 2.42 | 3.01 | 11.00 | 12.32 |
90 Days Ago | 2.62 | 3.04 | 11.01 | 12.37 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.39 | 3.01 | 11.02 | 12.28 |
Zacks Consensus Estimate | 2.39 | 3.01 | 10.99 | 12.35 |
Earnings ESP | 0.00% | 0.00% | 0.27% | -0.56% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.27 | 2.46 | 2.72 | 2.69 | NA |
Estimate | 2.05 | 2.39 | 2.35 | 2.63 | NA |
Difference | 0.22 | 0.07 | 0.37 | 0.06 | 0.18 |
Surprise | 10.73% | 2.93% | 15.74% | 2.28% | 7.92% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more